Sequence Similarity Clusters for the Entities in PDB 1MI5

Entity #1 | Chains: A
MHC heavy chain protein, length: 277 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 14 17 2664
95 % 138 158 217 Flexibility: Low
Max RMSD: 2.6, Avg RMSD: 1.0
PDBFlex
90 % 197 224 138
70 % 583 777 6
50 % 594 793 7
40 % 626 845 9
30 % 686 973 12
Entity #2 | Chains: B
beta 2 microglobulin protein, length: 99 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 539 706 2
95 % 550 721 2 Flexibility: Low
Max RMSD: 22.2, Avg RMSD: 0.9
PDBFlex
90 % 556 730 4
70 % 710 986 4
50 % 724 1010 3
40 % 724 1010 6
30 % 724 1010 9
Entity #3 | Chains: C
Epstein Barr Virus peptide protein, length: 9 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
Entity #4 | Chains: D
TcR alpha chain protein, length: 201 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 4 16264
95 % 2 4 15140 Flexibility: Low
Max RMSD: 1.7, Avg RMSD: 1.0
PDBFlex
90 % 5 11 3803
70 % 170 350 32
50 % 170 351 79
40 % 170 351 100
30 % 4345 7653 1
Entity #5 | Chains: E
TcR beta chain protein, length: 241 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 18606
95 % 5 7 7310 Flexibility: Low
Max RMSD: 1.5, Avg RMSD: 0.9
PDBFlex
90 % 6 9 5580
70 % 178 360 27
50 % 178 363 73
40 % 178 363 93
30 % 4346 7653 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
3 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
4 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
5 5IVN 1 A BC2-nanobody 30538
6 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
7 5E7B 1 A nanobody nano-L06 9838
8 2P45 2 B ANTIBODY CAB-RN05 9838
9 2X1Q 1 A, B GELSOLIN NANOBODY 9844
10 5U64 1 B VHH-28 9838
11 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
12 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
13 4B41 1 A, B ANTIBODY G7 9844
14 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
15 4NZU 1 L 13PL heavy chain Fab 9606
16 4NZU 2 H 13PL light chain Fab 9606
17 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
18 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
19 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
20 5IMM 1 B Nanobody 9835
21 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
22 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
23 5NLU 1 A single domain llama antibody Nb36 9844
24 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
25 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
27 1MEX 1 L Fab 29G12 light chain 10090
28 1MEX 2 H Fab 29G12 heavy chain 10090
29 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
30 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
31 5IMK 1 B Nanobody 9835
32 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
33 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
34 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
35 6EH4 2 E Human T Cell Receptor Beta Chain 9606
36 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
37 4BUH 1 A, B CLONE M0418 SCFV 9606
38 4B50 1 A 2H10 LLAMA VHH 9844
39 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
40 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
41 6FR4 1 A TCR 003 alpha chain 9606
42 6FR4 2 B TCR 003 Beta Chain 9606
43 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
44 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
45 6DBA 1 A, B nanobody VHH R303 9838
46 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
47 6EH5 2 B Human T Cell Receptor Beta Chain 9606
48 5YD4 1 A, C, E, G scFv 4B08 10090
49 5YD3 1 A, C, E, G scFv 4B08 10090
50 2XT1 2 B CAMELID VHH 9 30538
51 5UD9 1 H Fab heavy chain 9606
52 5UD9 2 L Light chain 9606
53 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
54 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
55 4P48 1 A Antibody scFv 180 9031
56 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
57 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
58 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
59 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
60 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
61 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
62 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
63 6FR3 1 A 003 TCR Alpha Chain 9606
64 6FR3 2 B 003 TCR Beta Chain 9606
65 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
66 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
67 5J1S 3 C VHH domain BS-2 30538
68 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
69 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
70 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
71 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
72 6MEE 2 B, D antibody HEPC74 Light Chain 9606
73 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
74 6BJZ 1 H 5c8 Fab Heavy chain 9606
75 6BJZ 2 L 5c8 Fab Light chain 9606
76 5L6Q 1 A, B H5AL 9606
77 5J1T 3 C VHH domain BS-2 30538
78 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
79 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
80 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
81 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
82 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
83 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
84 4XCF 1 L 4E10 Fab light chain 9606
85 4XCF 2 H 4E10 Fab heavy chain 9606
86 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
87 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
88 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
89 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
90 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
91 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
92 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
93 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
94 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
95 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
96 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
97 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
98 5X08 1 H Fab 4E10 Heavy chain 9606
99 5X08 2 L Fab 4E10 Light chain 9606
100 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
101 6MEG 1 H antibody HEPC46 Heavy Chain 9606
102 6MEG 2 L antibody HEPC46 Light Chain 9606
103 2X1O 1 A, B GELSOLIN NANOBODY 9844
104 4QGY 1 A, B nanobody n25, VH domain 9844
105 5C2B 1 H scFv 3B4 heavy chain 9606
106 5C2B 2 L 3B4 light chain 9606
107 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
108 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
109 4XAW 1 L 4E10 Fab light chain 9606
110 4XAW 2 H 4E10 Fab heavy chain 9606
111 5VNV 1 A Nb.b201 32630
112 4P49 1 A Antibody scFv B8 9031
113 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
114 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
115 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
116 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
117 5DXW 1 A PD-L1 nanobody 10090
118 2NW2 1 A ELS4 TCR alpha chain 9606
119 2NW2 2 B ELS4 TCR beta chain 9606
120 5UCB 1 H Fab Heavy Chain 9606
121 5UCB 2 L Fab Light Chain 9606
122 3T0W 1 A, B immunoglobulin variable lambda domain 9606
123 2VXV 1 H HUMAN IGG ABT-325 9606
124 2VXV 2 L HUMAN IGG ABT-325 9606
125 4N9O 2 B Nanobody Nb484 Nb484 9844
126 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
127 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
128 3T0V 1 A immunoglobulin variable lambda domain 9606
129 4GXV 1 H, I Antibody 1F1, heavy chain 9606
130 4GXV 2 L, M Antibody 1F1, light chain 9606
131 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
132 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
133 2VXT 1 H MURINE IGG 125-2H 10090
134 2VXT 3 L MURINE IGG 125-2H 10090
135 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
136 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
137 1T2J 1 A M12-Variable Heavy domain 9606
138 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
139 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
140 6DBF 2 B InlB specific VHH R303 9838
141 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
142 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
143 6DBG 2 C, D VHH R303 9838
144 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
145 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
146 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
147 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
148 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
149 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
150 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
151 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
152 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
153 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
154 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
155 5W24 1 L 5C4 Fab Light Chain 10090
156 5W24 2 H 5C4 Fab Heavy Chain 10090
157 4HPY 1 H CH59 Fab heavy chain 9606
158 4HPY 2 L CH59 Fab light chain 9606
159 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
160 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
161 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
162 5VM6 1 A single domain camelid nanobody VHH T10 9844
163 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
164 4JG1 1 L Fab light chain 9606
165 4JG1 2 H Fab heavy chain 9606
166 1SQ2 2 N novel antigen receptor 7801
167 6E65 1 L TB31F Fab light chain 9606
168 6E65 2 H TB31F Fab heavy chain 9606
169 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
170 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
171 4KML 2 B Nanobody 9844
172 5VF2 1 A scFv 2D10 10090
173 5I8C 1 A VRC34.01 Fab heavy chain 9606
174 5I8C 2 B VRC34.01 Fab light chain 9606
175 4O5L 1 L Fab F045-092 light chain 9606
176 4O5L 2 H Fab F045-092 heavy chain 9606
177 5MYX 1 A, C Fab c#24 light chain 10090
178 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
179 4Z9K 2 B VHH2(F5) antibody 30538
180 3IFL 1 L 12A11 FAB antibody light chain 10090
181 3IFL 2 H 12A11 FAB antibody heavy chain 10090
182 5WK2 1 L M116 LIGHT CHAIN 9606
183 5WK2 2 H M116 HEAVY CHAIN FD 9606
184 3PP4 1 H GA101 Fab heavy chain 10090
185 3PP4 2 L GA101 Fab light chain 10090
186 3KDM 1 A, L Immunoglobulin light chain 9606
187 3KDM 2 B, H Immunoglobulin heavy chain 9606
188 5NIV 1 A Light chain of 5D3 Fab 10090
189 5NIV 2 B Heavy chain of 5D3 Fab 10090
190 5N4J 1 L LIGHT CHAIN 9606
191 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
192 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
193 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
194 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
195 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
196 5X4G 1 A 6H8 Fab heavy chain 10090
197 5X4G 2 B 6H8 Fab light chain 10090
198 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
199 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
200 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
201 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
202 4PTU 1 A Antibody pn132p2C05, light chain 9606
203 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
204 4TPR 1 L If kappa light chain 10090
205 4TPR 2 H Fab heavy chain 10090
206 5LMW 1 A Nanobody 9844
207 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
208 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
209 3IFN 1 H 12A11 FAB antibody heavy chain 10090
210 3IFN 2 L 12A11 FAB antibody light chain 10090
211 5U3P 1 H DH511.4 Fab Heavy Chain 9606
212 5U3P 2 L DH511.4 Fab Light Chain 9606
213 6BLA 1 H AMM01 Fab Heavy chain 9606
214 6BLA 2 L AMM01 Fab Light chain 9606
215 5NM0 1 A, B, C, D Nb36 9844
216 4TOY 1 H 35O22 Fab Heavy chain 9606
217 4TOY 2 L 35O22 Fab Light chain 9606
218 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
219 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
220 3NPS 2 B S4 FAB HEAVY CHAIN 9606
221 3NPS 3 C S4 FAB LIGHT CHAIN 9606
222 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
223 5I4F 1 A scFv 2D10 10090
224 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
225 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
226 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
227 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
228 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
229 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
230 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
231 5WN9 1 H scFv 2D10 9606
232 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
233 4XC3 1 L 4E10 Fab light chain 9606
234 4XC3 2 H 4E10 Fab heavy chain 9606
235 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
236 4PPT 1 A Engineered single domain VHH antibody 9844
237 3R0M 1 A, B Llama VHH A12 9844
238 4M5Y 1 H, I Fab 5J8 heavy chain 9606
239 4M5Y 2 L, M Fab 5J8 light chain 9606
240 4TQE 1 L If kappa light chain 10090
241 4TQE 2 H Fab heavy chain 10090
242 3ZKQ 2 D XA4813 9844
243 5YY4 1 A scFv 4B08 10090
244 4I13 2 B Protein ca1697 (nanobody) 9844
245 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
246 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
247 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
248 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
249 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
250 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
251 5C2U 1 B Nanobody Nanobody 9838
252 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
253 5VSI 2 L CH1/Ckappa Fab light chain 9606
254 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
255 1XFP 1 A heavy chain antibody VHH domain 9838
256 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
257 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
258 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
259 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
260 5JXA 1 H VRC03 Heavy chain 9606
261 5JXA 2 L VRC03 Light chain 9606
262 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
263 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
264 4POY 1 A VHH-metal 9844
265 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
266 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
267 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
268 5NLW 1 A nanobody Nb36 9844
269 3CDC 1 A, B Light Chain Amyloidogenic 9606
270 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
271 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
272 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
273 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
274 3NTC 1 L Fab light chain 10090
275 3NTC 2 H Fab heavy chain 10090
276 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
277 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
278 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
279 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
280 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
281 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
282 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
283 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
284 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
285 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
286 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
287 6BE3 1 H Fab (F598) Heavy Chain 9606
288 6BE3 2 L Fab (F598) Light Chain 9606
289 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
290 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
291 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
292 3G9A 2 B Minimizer 9838
293 4NWU 1 H APE1551 Ab Fab heavy chain 9606
294 4NWU 2 L APE1551 Ab Fab light chain 9606
295 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
296 1KGC 1 D T-cell receptor alpha chain 9606
297 1KGC 2 E T-cell receptor beta chain 9606
298 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
299 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
300 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
301 6FRC 2 B Human T-Cell Receptor beta Chain 9606
302 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
303 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
304 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
305 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
306 5EWI 1 H VRC38.01 Heavy Chain 9606
307 5EWI 2 L VRC38.01 Light Chain 9606
308 5E2W 1 L AT8 LIGHT CHAIN 10090
309 5E2W 2 H AT8 HEAVY CHAIN 10090
310 5MYK 1 A Fab c#17 light chain 10090
311 5MYK 2 B Fab c#17 heavy chain 10090
312 6FUQ 1 A Human F11 T-Cell Receptor 9606
313 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
314 4NZR 1 H PGT135 heavy chain Fab 9606
315 4NZR 2 L PGT135 light chain Fab 9606
316 5MYO 1 A, C Fab c#6 light chain 10090
317 5MYO 2 B, D Fab c#6 heavy chain 10090
318 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
319 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
320 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
321 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
322 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
323 5UEL 1 H 354NC102 Fab Heavy Chain 9606
324 5UEL 2 L 354NC102 Fab Light Chain 9606
325 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
326 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
327 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
328 2P43 2 B ANTIBODY CAB-RN05 9838
329 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
330 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
331 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
332 5E2V 1 L AT8 LIGHT CHAIN 10090
333 5E2V 2 H AT8 HEAVY CHAIN 10090
334 4KRN 1 A Nanobody/VHH domain EgA1 9844
335 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
336 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
337 4GFT 2 B Nanobody 9844
338 4TVS 2 a, b VHH Domain BS-1 30538
339 4W6Y 2 B Nanobody NbFedF9 9844
340 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
341 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
342 6EZW 1 B VHH antibody BCD090-M2 9844
343 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
344 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
345 5JUE 1 L light chain of UIC2 Fab 10090
346 5JUE 2 H heavy chain of UIC2 Fab 10090
347 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
348 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
349 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
350 1UAC 2 H Ig VH,anti-lysozyme 10090
351 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
352 5JR1 1 H 10E8 heavy chain 9606
353 5JR1 2 L 10E8 mature light chain 9606
354 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
355 6CA7 1 L PCT64_13C light chain 9606
356 6CA7 2 H PCT64_13C heavy chain 9606
357 5VF6 1 A single chain variable fragment 9031
358 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
359 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
360 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
361 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
362 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
363 6FR9 2 B T-Cell Receptor F11 beta chain 9606
364 5OB5 2 H fAb Heavy chain 9606
365 5OB5 3 L fAb Light chain 9606
366 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
367 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
368 5I66 1 A 8B6 antibody, heavy chain 10090
369 5I66 2 B 8B6 antibody, light chain 10090
370 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
371 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
372 6BZY 1 H 22D11 Heavy Chain 10090
373 6BZY 2 L 22D11 Light Chain 10090
374 3QQ9 1 C, L 101F LIGHT CHAIN 10090
375 3QQ9 2 D, H 101F HEAVY CHAIN 10090
376 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
377 5TKK 3 L mouse antibody vFP5.01 light chain 10090
378 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
379 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
380 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
381 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
382 5W6C 1 H UCA Fab heavy chain 9606
383 5W6C 2 L UCA Fab light chain 9606
384 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
385 5I1K 1 L FAB LIGHT CHAIN 9606
386 5I1K 2 H FAB HEAVY CHAIN 9606
387 3OZ9 1 L Fab NC-1 kappa light chain 10090
388 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
389 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
390 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
391 5V7U 1 L CBTAU-22.1 Fab light chain 9606
392 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
393 5UEA 1 A, H Fab Heavy Chain 9606
394 5UEA 3 B, L Fab Light Chain 9606
395 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
396 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
397 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
398 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
399 3G5Y 1 A 175 light chain 10090
400 3G5Y 2 B 175 heavy chain 10090
401 5O02 2 C Nanobody (VHH) Nano-4 30538
402 5NMV 1 L Fab light chain 10088
403 5NMV 2 H Fab heavy chain 10088
404 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
405 4N8C 2 L, M Light chain of monoclonal antibody 10090
406 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
407 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
408 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
409 4HGW 1 A Antibody Fab fragment, light chain 10090
410 4HGW 2 B Antibody Fab fragment, heavy chain 10090
411 1NLB 1 L antibody 19D9D6 light chain 10090
412 1NLB 2 H antibody 19D9D6 heavy chain 10090
413 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
414 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
415 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
416 3VFG 1 L 3F8 Light Chain 10090
417 3VFG 2 H 3F8 Heavy Chain 10090
418 4X7F 2 C, D Nano-25 Nanobody 30538
419 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
420 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
421 3QRG 1 L Fab light chain 9606
422 3QRG 2 H Fab heavy chain Fd fragment 9606
423 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
424 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
425 5M6A 1 A, B, C, D Bence-Jones light chain 9606
426 4LLY 2 B, D light chain Clambda 9606
427 4LGR 2 B Camelid nanobody (VHH3) 30538
428 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
429 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
430 5EZI 1 H Fab c12 heavy chain 9606
431 5EZI 2 L Fab c12 Light chain 9606
432 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
433 4K23 1 H anti-uPAR antibody, heavy chain 10090
434 4K23 2 L anti-uPAR antibody, light chain 10090
435 5J57 2 B VHH single chain antibody V5E1 30538
436 3NCJ 1 L Fab15 Mut8 light chain 9606
437 3NCJ 2 H Fab15 Mut8 heavy chain 9606
438 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
439 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
440 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
441 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
442 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
443 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
444 5W05 1 L M59 FAB LIGHT CHAIN 10090
445 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
446 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
447 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
448 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
449 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
450 5OMM 2 C Nanobody (VHH) Nano-14 30538
451 5E03 1 A mouse CTLA-4 nanobody 10090
452 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
453 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
454 4M61 1 A, C Fab A52 light chain 10090
455 4M61 2 B, D Fab A52 heavy chain 10090
456 5YE3 1 B 2A7D9 VH CH1 chain 10090
457 5YE3 2 A 2A7D9 L chain 10090
458 5LZ0 1 A, B PorM nanobody 9844
459 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
460 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
461 1UM5 1 L Antibody 21H3 L chain 10090
462 1UM5 2 H Antibody 21H3 H chain 10090
463 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
464 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
465 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
466 4NWT 1 L APE1531 Ab Fab light chain 9606
467 4NWT 2 H APE1531 Ab Fab heavy chain 9606
468 6DBE 1 A, B nanobody VHH R303 9844
469 3WHX 1 A mAb Fab H fragment 10090
470 3WHX 2 B mAb Fab L fragment 10090
471 3NA9 1 L Fab15 light chain 9606
472 3NA9 2 H Fab15 heavy chain 9606
473 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
474 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
475 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
476 6FUO 2 B Human F11 T-Cell Receptor 9606
477 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
478 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
479 4LRI 1 A, B MSL-109 Light Chain 9606
480 4LRI 2 C, P MSL-109 Heavy Chain 9606
481 2XXC 1 B CAMELID VHH 9 30538
482 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
483 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
484 4JN2 1 A, L anti dabigatran Fab 10090
485 4JN2 2 B, H anti dabigatran Fab 10090
486 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
487 4XBE 2 H 4E10 Fab heavy chain 9606
488 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
489 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
490 6BE2 1 H Fab (F598) Heavy Chain 9606
491 6BE2 2 L Fab (F598) Light Chain 9606
492 3QYC 1 A, B VH domain of IgG molecule 9606
493 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
494 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
495 4JFZ 1 L Fab light chain 9606
496 4JFZ 2 H Fab heavy chain 9606
497 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
498 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
499 5VAK 2 B Nb914 Nanobody 9844
500 3WIF 1 A mAb Fab H fragment 10090
501 3WIF 2 B mAb Fab L fragment 10090
502 5U6A 1 A Light Chain 9606
503 5U6A 2 B Heavy Chain 9606
504 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
505 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
506 3MBX 1 L X836 LIGHT CHAIN 10090
507 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
508 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
509 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
510 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
511 2XXM 2 B CAMELID VHH 9 30538
512 6APC 1 H Epididymis luminal protein 214 9606
513 6APC 2 L IGL@ protein 9606
514 6BJ8 3 D TCR 55 alpha chain 9606
515 6BJ8 4 H TCR 55 beta chain 9606
516 5IR3 1 A Ig lambda chain V-VI region AR 9606
517 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
518 4HHA 1 A Fab KE5 Fab fragment KE5 9606
519 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
520 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
521 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
522 4RGO 2 H 14G8 heavy chain Fab 10090
523 4RGO 3 L 14G8 light chain Fab 10090
524 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
525 5GRY 1 A, G diabody 9606
526 5UEK 2 H Fab 12E Heavy Chain 9606
527 5UEK 3 L Fab 12E Light Chain 9606
528 3NAA 1 L Fab15 Mut5 light chain 9606
529 3NAA 2 H Fab15 Mut5 heavy chain 9606
530 6DBD 1 A, B, C, D nanobody VHH R326 9844
531 1Q0X 1 L Fab 9B1, light chain 10090
532 1Q0X 2 H Fab 9B1, heavy chain 10090
533 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
534 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
535 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
536 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
537 5JDS 1 B Nanobody 9835
538 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
539 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
540 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
541 5IK3 2 B, D 1E03 Fab fragment light chain 9606
542 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
543 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
544 5XLI 1 a, b FabL 10090
545 5XLI 2 c, d FabH 10090
546 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
547 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
548 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
549 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
550 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
551 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
552 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
553 4WUK 1 H CH65 heavy chain 9606
554 4WUK 2 L CH65 light chain 9606
555 5L8L 2 B New antigen receptor variable domain 168098
556 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
557 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
558 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
559 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
560 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
561 5JOP 1 D, L Fab 14.22 light chain 10090
562 5JOP 2 E, H Fab14.22 heavy chain 10090
563 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
564 4HPO 1 H CH58 Fab heavy chain 9606
565 4HPO 2 L CH58 Fab light chain 9606
566 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
567 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
568 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
569 5UKN 2 L DH522UCA Fab fragment light chain 9544
570 4AIZ 1 A, C, D V2-17 PROTEIN 9606
571 4AIZ 2 B V2-17 PROTEIN 9606
572 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
573 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
574 5L21 2 B VHH-C2 30538
575 5IT2 1 H heavy chain 9606
576 5IT2 2 L light chain 9606
577 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
578 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
579 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
580 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
581 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
582 2W59 1 A, B IGY FCU3-4 9031
583 5FWO 1 A NANOBODY 9844
584 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
585 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
586 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
587 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
588 4L1H 1 A Ig kappa chain V-I region Rei 9606
589 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
590 5MO3 3 L Fab of monoclonal antibody, light chain 10090
591 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
592 5GZ0 1 A, C FM329 light chain 1383439
593 5GZ0 2 B, D FM329 heavy chain 1383439
594 6DW2 1 A 6078 Fab light chain 9606
595 6DW2 2 B 6078 Fab heavy chain 9606
596 3B9V 1 A, B, C, D heavy chain variable domain 9606
597 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
598 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
599 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
600 6BQB 1 L MGG4 Fab light chain 9606
601 6BQB 2 H MGG4 Fab heavy chain 9606
602 4PUB 1 H DX-2930 HEAVY CHAIN 9606
603 4PUB 2 L DX-2930 LIGHT CHAIN 9606
604 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
605 6B14 2 L Light chain of Fab BL3-6S97N 10090
606 5N88 1 A, H VH59 antibody 9606
607 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
608 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
609 5TEZ 4 I TCR F50 alpha chain 9606
610 5TEZ 5 J TCR F50 beta chain 9606
611 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
612 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
613 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
614 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
615 5GS3 1 A, H diabody protein 9606
616 3BD3 1 A, B catalytic antibody 10090
617 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
618 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
619 2OTU 1 A, C, E, G Fv light chain variable domain 10090
620 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
621 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
622 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
623 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
624 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
625 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
626 5VKD 2 H Fab Heavy Chain 9606
627 5VKD 3 L Fab light chain 9606
628 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
629 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
630 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
631 5XHG 1 A, C polypeptide(L) 10090
632 5XHG 2 B, D polypeptide(H) 10090
633 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
634 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
635 5L8J 2 B New antigen receptor variable domain 168098
636 3UYR 1 H antibody Fab heavy chain 10090
637 3UYR 2 L antibody Fab light chain 10090
638 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
639 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
640 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
641 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
642 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
643 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
644 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
645 3OAZ 2 K, L Fab 2G12, light chain 9606
646 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
647 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
648 1T6V 2 N, O novel antigen receptor 7801
649 1ZAN 1 L Fab AD11 Light Chain 10116
650 1ZAN 2 H Fab AD11 Heavy Chain 10116
651 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
652 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
653 6CJK 1 A, C Immunoglobulin Fab light chain 9986
654 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
655 4N0Y 1 H IGH526 Heavy Chain 9606
656 4N0Y 2 L IGH526 Light Chain 9606
657 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
658 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
659 5MTH 1 A, H antibody Fab heavy chain 10090
660 5MTH 2 B, L antibody Fab light chain 10090
661 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
662 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
663 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
664 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
665 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
666 1RZF 1 L Fab E51 light chain 9606
667 1RZF 2 H Fab E51 heavy chain 9606
668 4N1C 1 A, B immunoglobulin variable light chain domain 9606
669 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
670 4KTE 2 L GE148 Light Chain Fab 9544
671 5I8O 1 H HMM5 antibody heavy chain 9606
672 5I8O 2 L HMM5 antibody light chain 9606
673 4OUO 1 A anti Bla g 1 scFv 9031
674 4JG0 1 L Fab light chain 9606
675 4JG0 2 H Fab heavy chain 9606
676 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
677 4YGV 2 B, L aDabi-Fab2a light chain 9606
678 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
679 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
680 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
681 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
682 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
683 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
684 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
685 3EO0 1 A, C GC-1008 Fab Light Chain 10090
686 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
687 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
688 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
689 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
690 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
691 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
692 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
693 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
694 6FUR 2 B, D Human F11 T-Cell Receptor 9606
695 4POU 2 B VHH Antibody 9844
696 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
697 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
698 4FQI 3 H antibody CR9114 heavy chain Fab 9606
699 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
700 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
701 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
702 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
703 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
704 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
705 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
706 4JHA 2 L D25 light chain 9606
707 6B9Z 1 A Trastuzumab Fab light chain 10090
708 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
709 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
710 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
711 4PTT 1 A Antibody pn132p2C05, light chain 9606
712 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
713 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
714 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
715 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
716 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
717 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
718 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
719 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
720 2P42 2 B, D ANTIBODY CAB-RN05 9838
721 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
722 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
723 6CPH 1 D TCR alpha chain 9606
724 6CPH 2 E TCR beta chain 9606
725 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
726 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
727 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
728 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
729 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
730 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
731 4DGV 1 H HCV1 Heavy Chain Fab 9606
732 4DGV 2 L HCV1 Light Chain 9606
733 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
734 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
735 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
736 5TH2 1 A, C cetuximab Fab, light chain 10090
737 5TH2 2 B, D cetuximab Fab, heavy chain 10090
738 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
739 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
740 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
741 5I8K 1 L HHH1 Fab Light chain 9606
742 5I8K 2 H HHH1 Fab Heavy chain 9606
743 4QLR 1 A, B Llama nanobody n02 VH domain 9844
744 5J56 2 B VHH single chain antibody V1C7 30538
745 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
746 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
747 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
748 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
749 1YNL 1 L Ig gamma light chain 10090
750 1YNL 2 H Ig gamma heavy chain 10090
751 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
752 5EPM 2 B, F Antibody Fab fragment light chain 10090
753 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
754 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
755 5VH5 1 A Infliximab Fc 10090
756 3UMT 1 A scFv heavy chain and light chain 10090
757 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
758 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
759 4NUJ 1 A PGT152 light chain 9606
760 4NUJ 2 B PGT152 heavy chain 9606
761 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
762 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
763 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
764 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
765 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
766 3U2S 2 B, L PG9 light chain 9606
767 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
768 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
769 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
770 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
771 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
772 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
773 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
774 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
775 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
776 4NUG 1 L PGT151 light chain 9606
777 4NUG 2 H PGT151 heavy chain 9606
778 3IU4 1 H chP3 Fab heavy chain 10090
779 3IU4 2 L chP3 Fab light chain 10090
780 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
781 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
782 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
783 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
784 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
785 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
786 1P7K 1 A, L antibody light chain FAB 10090
787 1P7K 2 B, H antibody heavy chain FAB 10090
788 4NBX 2 B A20.1 VHH 9844
789 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
790 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
791 3RVV 2 C 4C1 - light chain 10090
792 3RVV 3 D 4C1 - heavy chain 10090
793 4HEP 2 G vHH17 domain 9844
794 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
795 3P0Y 2 H Fab DL11 heavy chain 9606
796 3P0Y 3 L Fab DL11 light chain 9606
797 4NPY 1 A, L germline PGT121 light chain Fab 9606
798 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
799 6ANA 2 H LL2 Fab Heavy Chain 10090
800 6ANA 3 L LL2 Fab Light Chain 10090
801 5IBU 1 B, L 6652 Light Chain 9606
802 5IBU 2 G, H 6652 Heavy Chain 9606
803 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
804 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
805 5VPL 2 C 4C1 - LIGHT CHAIN 10090
806 5VPL 3 D 4C1 - HEAVY CHAIN 10090
807 6AOD 1 A FXIa Antibody FAB Light Chain 9606
808 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
809 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
810 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
811 2YPV 2 H FAB 12C1 10090
812 2YPV 3 L FAB 12C1 10090
813 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
814 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
815 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
816 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
817 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
818 4JY5 1 L PGT122 light chain Fab 9606
819 4JY5 2 H PGT122 heavy chain Fab 9606
820 6ELE 1 A, H fAB heavy chain 9606
821 6ELE 2 B, L fAB light chain 9606
822 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
823 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
824 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
825 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
826 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
827 6B5R 1 H CIS42 Fab Heavy chain 9606
828 6B5R 2 L CIS42 Fab Light chain 9606
829 5IML 2 B Nanobody 9835
830 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
831 3NAC 1 L Fab15 Mut7 light chain 9606
832 3NAC 2 H Fab15 Mut7 heavy chain 9606
833 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
834 3A6C 2 H IG VH, anti-lysozyme 10090
835 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
836 2DQD 2 H Ig VH,anti-lysozyme 10090
837 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
838 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
839 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
840 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
841 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
842 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
843 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
844 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
845 1Q72 1 L Fab M82G2, Light chain 10090
846 1Q72 2 H Fab M82G2, Heavy chain 10090
847 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
848 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
849 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
850 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
851 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
852 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
853 4YHO 1 H aDabi-Fab3 heavy chain 9606
854 4YHO 2 L aDabi-Fab3 light chain 9606
855 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
856 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
857 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
858 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
859 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
860 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
861 4DGY 1 H HCV1 Heavy Chain Fab 9606
862 4DGY 2 L HCV1 Light Chain 9606
863 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
864 3A67 2 H IG VH, anti-lysozyme 10090
865 2APB 1 A T-cell receptor beta chain V 10116
866 2APX 1 A T cell receptor beta chain V 10116
867 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
868 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
869 6EH6 2 B Human T Cell Receptor BetaChain 9606
870 5EN2 1 A GD01 heavy chain 10090
871 5EN2 2 B GD01 light chain 10090
872 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
873 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
874 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
875 1J1X 2 H Ig VH,anti-lysozyme 10090
876 5L8K 2 B New antigen receptor variable domain 168098
877 5M2J 2 D Anti-(ED-B) scFV 9606
878 3MXW 2 L 5E1 light chain 9606
879 3MXW 3 H 5E1 heavy chain 9606
880 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
881 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
882 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
883 2DQC 2 H Ig VH,anti-lysozyme 10090
884 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
885 1J1O 2 H Ig VH,anti-lysozyme 10090
886 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
887 3EO9 1 L Efalizumab Fab fragment, light chain 9606
888 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
889 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
890 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
891 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
892 4M62 2 H, I GEP2 FV heavy chain 9606
893 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
894 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
895 5IVO 1 A BC2-nanobody 30538
896 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
897 1J1P 2 H Ig VH,anti-lysozyme 10090
898 6N35 1 K, L Fab 2G12 light chain 9606
899 6N35 2 H, M Fab 2G12 heavy chain 9606
900 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
901 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
902 4NBZ 2 B, D A26.8 VHH 9844
903 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
904 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
905 5WUV 1 L light chain 9606
906 5WUV 2 H heavy chain 9606
907 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
908 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
909 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
910 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
911 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
912 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
913 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
914 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
915 5AYU 2 H Ig VH,anti-lysozyme 10090
916 4JM4 1 H PGT 135 Heavy Chain Fab 9606
917 4JM4 2 L PGT 135 Light Chain Fab 9606
918 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
919 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
920 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090